share_log

Craig-Hallum Initiates Coverage On Maravai LifeSciences With Buy Rating, Announces Price Target of $15

Moomoo 24/7 ·  Apr 10 08:09

Craig-Hallum analyst Christian Schwab initiates coverage on Maravai LifeSciences (NASDAQ:MRVI) with a Buy rating and announces Price Target of $15.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment